Investigating how certain genetic factors affect breast cancer that doesn't respond to hormone therapy
Epigenetic dependencies and vulnerabilities in endocrine-resistant breast cancer
This study is looking into why some breast cancers don't respond to hormone treatments and hopes to find new ways to help patients by understanding the genetic factors involved, so they can get better, more personalized care.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Miami School of Medicine NIH-funded |
| Lab location | 1 site (Coral Gables, United States) |
| Project ID | NIH-11049574 on NIH RePORTER |
What this research studies
This research focuses on understanding the genetic and epigenetic factors that contribute to breast cancer's resistance to hormone therapies. Specifically, it examines the CoREST-SWI/SNF axis, which plays a role in how breast cancer cells adapt and survive despite treatment. By identifying these vulnerabilities, the research aims to develop new therapeutic strategies that could improve outcomes for patients with endocrine-resistant breast cancer. Patients may benefit from insights that lead to more effective treatments tailored to their specific cancer characteristics.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with estrogen receptor-positive breast cancer who have developed resistance to hormone therapies.
Not a fit: Patients with breast cancer that is not estrogen receptor-positive or those who have not undergone hormone therapy may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatment options that significantly improve survival rates for patients with endocrine-resistant breast cancer.
How similar studies have performed: Previous research has shown promise in targeting epigenetic mechanisms in cancer treatment, suggesting that this approach could yield significant advancements.
Where this research is happening
Coral Gables, United States
- University of Miami School of Medicine — Coral Gables, United States (Active)
Researchers
- Principal investigator: Morey, Lluis — University of Miami School of Medicine
- Study coordinator: Morey, Lluis
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.